These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19917391)

  • 61. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation.
    Diamond DL; Krasnoselsky AL; Burnum KE; Monroe ME; Webb-Robertson BJ; McDermott JE; Yeh MM; Dzib JF; Susnow N; Strom S; Proll SC; Belisle SE; Purdy DE; Rasmussen AL; Walters KA; Jacobs JM; Gritsenko MA; Camp DG; Bhattacharya R; Perkins JD; Carithers RL; Liou IW; Larson AM; Benecke A; Waters KM; Smith RD; Katze MG
    Hepatology; 2012 Jul; 56(1):28-38. PubMed ID: 22331615
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liver transplantation 27 years after bone marrow transplantation from the same living donor.
    Andreoni KA; Lin JI; Groben PA
    N Engl J Med; 2004 Jun; 350(25):2624-5. PubMed ID: 15201426
    [No Abstract]   [Full Text] [Related]  

  • 64. Total antioxidant capacity and lipid peroxidation during liver transplantation.
    Galley HF; Richardson N; Howdle PD; Walker BE; Webster NR
    Clin Sci (Lond); 1995 Sep; 89(3):329-32. PubMed ID: 7493431
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oxidant stress in type I autoimmune hepatitis: the link between necroinflammation and fibrogenesis?
    Pemberton PW; Aboutwerat A; Smith A; Burrows PC; McMahon RF; Warnes TW
    Biochim Biophys Acta; 2004 Aug; 1689(3):182-9. PubMed ID: 15276644
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Efficiency of enterosorbent white coal* in the treatment of patients with hepatic cirrhosis].
    Frolov VM; Sotskaia IaA; Peresadin NA; Kruglova OV
    Lik Sprava; 2012 Dec; (8):108-15. PubMed ID: 23786023
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies.
    Berretta M; Quagliariello V; Maurea N; Di Francia R; Sharifi S; Facchini G; Rinaldi L; Piezzo M; Manuela C; Nunnari G; Montopoli M
    Antioxidants (Basel); 2020 Nov; 9(12):. PubMed ID: 33256059
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Associations of Oxidative Stress and Postoperative Outcome in Liver Surgery with an Outlook to Future Potential Therapeutic Options.
    Senoner T; Schindler S; Stättner S; Öfner D; Troppmair J; Primavesi F
    Oxid Med Cell Longev; 2019; 2019():3950818. PubMed ID: 30906502
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of liver biopsy in detection of hepatic oxidative stress.
    Abd Ellah MR
    Vet Med Int; 2011 Feb; 2011():613602. PubMed ID: 21403828
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiviral treatment for hepatitis C virus infection after liver transplantation.
    Sugawara Y; Tamura S; Kokudo N
    Hepat Res Treat; 2010; 2010():475746. PubMed ID: 21151523
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatic lipid peroxidation and antioxidant micronutrients in hepatitis virus C liver recipients with and without disease recurrence.
    Madill J; Arendt BM; Aghdassi E; Therapondos G; Lilly L; Chow CW; Guindi M; Allard JP
    Transplant Proc; 2009 Nov; 41(9):3800-5. PubMed ID: 19917391
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oxidative stress and nutritional factors in hepatitis C virus-positive liver recipients, controls, and hepatitis C virus-positive nontransplant patients.
    Madill J; Arendt B; Aghdassi E; Chow C; Guindi M; Therapondos G; Lilly L; Allard J
    Transplant Proc; 2010 Jun; 42(5):1744-9. PubMed ID: 20620514
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.